Matches in Wikidata for { <http://www.wikidata.org/entity/Q66069607> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q66069607 description "clinical trial" @default.
- Q66069607 description "ensayu clínicu" @default.
- Q66069607 description "klinisch onderzoek" @default.
- Q66069607 description "клінічне випробування" @default.
- Q66069607 description "կլինիկական փորձարկում" @default.
- Q66069607 name "Pembrolizumab for the Treatment of Recurrent High Grade Neuroendocrine Carcinoma" @default.
- Q66069607 name "Pembrolizumab for the Treatment of Recurrent High Grade Neuroendocrine Carcinoma" @default.
- Q66069607 type Item @default.
- Q66069607 label "Pembrolizumab for the Treatment of Recurrent High Grade Neuroendocrine Carcinoma" @default.
- Q66069607 label "Pembrolizumab for the Treatment of Recurrent High Grade Neuroendocrine Carcinoma" @default.
- Q66069607 prefLabel "Pembrolizumab for the Treatment of Recurrent High Grade Neuroendocrine Carcinoma" @default.
- Q66069607 prefLabel "Pembrolizumab for the Treatment of Recurrent High Grade Neuroendocrine Carcinoma" @default.
- Q66069607 P1132 Q66069607-47666684-3FA8-44D8-A91E-B2FBA1C9CBF9 @default.
- Q66069607 P1476 Q66069607-34EB981B-9335-4613-9651-00D7B8D7BADC @default.
- Q66069607 P17 Q66069607-5873CEC9-569A-40DA-8132-033F3E1FF63F @default.
- Q66069607 P1813 Q66069607-43832487-2D67-4323-9CBB-9488FA0D1F83 @default.
- Q66069607 P2899 Q66069607-16A7CE89-8F44-4AB1-82D7-B627CC9E2EC6 @default.
- Q66069607 P3098 Q66069607-A689C766-1E4D-4CCF-B521-5011CEA54F73 @default.
- Q66069607 P31 Q66069607-CEBD4127-4DEA-4D39-AE91-F7CA9499C3E7 @default.
- Q66069607 P4844 Q66069607-4EECCB41-7444-4728-966D-EC9C4FEAE6DD @default.
- Q66069607 P580 Q66069607-5867259A-389F-42A9-ABB7-9CBB2C368B45 @default.
- Q66069607 P582 Q66069607-F55989F6-4F09-42A3-87F8-70FF911C8AC1 @default.
- Q66069607 P6099 Q66069607-900F6267-0E8B-4D90-8105-C1A8002BD6BF @default.
- Q66069607 P6153 Q66069607-A021CD4B-D71D-4ED7-A362-291086F26DA6 @default.
- Q66069607 P8363 Q66069607-62BC3722-6E80-4657-976D-156428B4113D @default.
- Q66069607 P1132 "+6" @default.
- Q66069607 P1476 "Pembrolizumab for the Treatment of Recurrent High Grade Neuroendocrine Carcinoma" @default.
- Q66069607 P17 Q30 @default.
- Q66069607 P1813 "Pembro NEC" @default.
- Q66069607 P2899 "+18" @default.
- Q66069607 P3098 "NCT03190213" @default.
- Q66069607 P31 Q30612 @default.
- Q66069607 P4844 Q13896859 @default.
- Q66069607 P580 "2017-12-04T00:00:00Z" @default.
- Q66069607 P582 "2018-12-13T00:00:00Z" @default.
- Q66069607 P6099 Q42824440 @default.
- Q66069607 P6153 Q56582915 @default.
- Q66069607 P8363 Q78089383 @default.